Anika Therapeutics, Inc.: capex
| Value | {"amount": 35802, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2013-01-01 – 2013-03-31 |
| Status | current |
| Entity | Anika Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:02:47.738007+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f8957be4-53a1-4aa8-832d-b3af8bcad9a5
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001157523-13-002386Retrieved: 2026-08-19T09:02:47.738007+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000898437/capex/2013-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f8957be4-53a1-4aa8-832d-b3af8bcad9a5
History
- no predecessors — first report